(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 8.05% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.55%.
Neuronetics's revenue in 2026 is $155,096,000.On average, 6 Wall Street analysts forecast STIM's revenue for 2026 to be $12,593,114,880, with the lowest STIM revenue forecast at $12,044,494,882, and the highest STIM revenue forecast at $13,025,153,129. On average, 6 Wall Street analysts forecast STIM's revenue for 2027 to be $13,758,932,377, with the lowest STIM revenue forecast at $13,067,823,573, and the highest STIM revenue forecast at $14,321,267,875.
In 2028, STIM is forecast to generate $14,904,176,623 in revenue, with the lowest revenue forecast at $14,180,303,014 and the highest revenue forecast at $15,481,751,566.